Host Biomarkers Distinguish Dengue from Leptospirosis in Colombia: a Case-control Study
Overview
Authors
Affiliations
Background: Dengue fever and leptospirosis have partially overlapping geographic distributions, similar clinical presentations and potentially life-threatening complications but require different treatments. Distinguishing between these cosmopolitan emerging pathogens represents a diagnostic dilemma of global importance. We hypothesized that perturbations in host biomarkers can differentiate between individuals with dengue fever and leptospirosis during the acute phase of illness.
Methods: We randomly selected subjects from a prospective cohort study of acute febrile illness in Bucaramanga, Colombia and tested 19 serum biomarkers by ELISA in dengue fever (DF, n = 113) compared to subjects with leptospirosis (n = 47). Biomarkers were selected for further analysis if they had good discriminatory ability (area under the ROC curve (AUC) >0.80) and were beyond a reference range (assessed using local healthy controls).
Results: Nine biomarkers differed significantly between dengue fever and leptospirosis, with higher levels of Angptl3, IL-18BP, IP-10/CXCL10, Platelet Factor 4, sICAM-1, Factor D, sEng and sKDR in dengue and higher levels of sTie-2 in leptospirosis (p < 0.001 for all comparisons). Two biomarkers, sEng and IL18BP, showed excellent discriminatory ability (AUROC >0.90). When incorporated into multivariable models, sEng and IL18BP improved the diagnostic accuracy of clinical information alone.
Conclusions: These results suggest that host biomarkers may have utility in differentiating between dengue and leptospirosis, clinically similar conditions of different etiology.
Elevated Plasma Angiopoietin-like 4 Protein Levels in Adult Patients with Dengue.
Khaing W, Lau S, Thein T, Tan N, Alonso S, Vasoo S Viruses. 2025; 17(2).
PMID: 40006981 PMC: 11861331. DOI: 10.3390/v17020226.
A Rare Complication of Leptospirosis: Weil's Disease Diagnosed in the United States.
Rathi H, Patel A, Beblawy R, Hassoun A Cureus. 2023; 15(8):e43620.
PMID: 37719584 PMC: 10504683. DOI: 10.7759/cureus.43620.
Parra Barrera E, Bello Piruccini S, Rodriguez K, Duarte C, Torres M, Undurraga E PLoS Negl Trop Dis. 2023; 17(7):e0011454.
PMID: 37406001 PMC: 10351742. DOI: 10.1371/journal.pntd.0011454.
The Role of Growth Factors in the Pathogenesis of Dengue: A Scoping Review.
Fiestas Solorzano V, de Lima R, de Azeredo E Pathogens. 2022; 11(10).
PMID: 36297236 PMC: 9608673. DOI: 10.3390/pathogens11101179.
Role of Platelet Cytokines in Dengue Virus Infection.
Singh A, Bisht P, Bhattacharya S, Guchhait P Front Cell Infect Microbiol. 2020; 10:561366.
PMID: 33102253 PMC: 7554584. DOI: 10.3389/fcimb.2020.561366.